نتایج جستجو برای: cotrimoxazole

تعداد نتایج: 1157  

Journal: :Bulletin of the National Research Centre 2021

Abstract Background Gastroenteritis is a common infectious disease in children, which results high mortality and morbidity, especially resource-poor countries. This study presents the selected main gastroenteritis causing bacteria, including Escherichia coli O157, Salmonella Shigella species delineating their prevalence resistance pattern to clinically used antibiotics. Results A total of 346 s...

Journal: :Medical Laboratory Technology Journal 2023

Methicillin-resistant Staphylococcus aureus (MRSA) is difficult to treat, causing considerable morbidity and mortality. Nasal carriage of MRSA can occur both in healthcare workers patients. Mupirocin used as a topical agent for the eradication such isolates. The present study aims prevalence mupirocin resistance among MSSA (Methicillin-sensitive aureus) A total 148 isolates were tested. Antibio...

2013
Russell Senanayake Mamoun Mukhtar

Cotrimoxazole is a commonly used antimicrobial agent which is traditionally indicated in the management of pneumocystis infection of which HIV and immunosuppressed individuals are at high risk. Furthermore, it can be used on the long term for prophylactic indications. Hypoglycaemia following commencement of cotrimaoxazole is a rare adverse effect which was first described in 1988. We describe a...

2005
Jesús Oteo Edurne Lázaro Francisco J. de Abajo Fernando Baquero José Campos

Surveillance System. A network of 32 Spanish hospitals, serving approximately 9.6 million persons, submitted antimicrobial-susceptibility data on 7,098 invasive Escherichia coli species (2001-2003). Resistance to ampicillin, cotrimoxazole, ciprofloxacin, gentamicin, and tobramycin was found at rates of 59.9%, 32.6%, 19.3%, 6.8%, and 5.3%, respectively. Resistance to multiple drugs increased fro...

2009
J. M KIMANDO P. O OKEMO

Escherichia coli is the predominant cause of urinary tract infections, and is gaining prominence in medical practice due to increasing resistance to widely used antimicrobials including some specified in the world Health Organization’s Model List of Essential Drugs. A cross-sectional analytical research design was conducted to determine the serotypes and antimicrobial resistance phenotypes of E...

2005
A. A. Shehabi

1Department of Pathology and Microbiology, Faculty of Medicine, University of Jordan, Amman, Jordan. Received: 27/01/03; accepted: 06/05/03 ABSTRACT We investigated antimicrobial resistance patterns and plasmid profiles of uropathogenic Escherichia coli isolates from inpatients and outpatients at Jordan University Hospital in 2000 and 2001. E. coli accounted for 32.4% and 37.4% of all isolates ...

Journal: :Antimicrobial agents and chemotherapy 1979
R M Robins-Brown M N Gaspar J I Ward I K Wachsmuth H J Koornhof M R Jacobs C Thornsberry

Strains of Streptococcus pneumoniae resistant to penicillin have been reported from several countries around the world. Many South African isolates, in addition, exhibit resistance to tetracycline, chloramphenicol, erythromycin, clindamycin, and cotrimoxazole in varying patterns. A qualitative test of the ability of antibiotic-resistant pneumococci to inactivate penicillin, oxacillin, cephaloth...

Journal: :British medical journal 1976
P E Gower P R Tasker

Treatment with cephalexin 1 g twiec daily and cotrimoxazole 2 tablets twice daily was compared in a double-blind, randomised study of 100 women with urinary tract infections. CO-trimoxazole gave a significantly higher cure rate compared with cephalexin two and six weeks after the one-week course of treatment. The higher failure rate with cephalexin was not related to the age of the patient, pre...

Journal: :Bulletin of the World Health Organization 2004
Christopher J Gill Lora L Sabin Joseph Tham Davidson H Hamer

Infants with HIV infection are vulnerable to Pneumocystis carinii pneumonia (PCP) during their first year of life. WHO and the Joint United Nations Programme on HIV/AIDS now recommend that all children of HIV-positive mothers receive prophylactic cotrimoxazole against PCP from six weeks of age and continue this therapy until exposure through breast milk ceases-and the infant is confirmed to be ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید